Bile acid-based advanced drug delivery systems, bilosomes and micelles as novel carriers for therapeutics.
Mohadeseh NematiAnahita Fathi-AzarbayjaniHani Al-SalamiElmira Roshani AslYousef RasmiPublished in: Cell biochemistry and function (2022)
Diabetes mellitus affects almost half a billion patients worldwide and results from either destruction of β-cells responsible for insulin secretion or increased tissue resistance to insulin stimulation and the reduction of glycemic control. Novel drug delivery systems can improve treatment efficacy in diabetic patients. The low aqueous solubility of most oral antidiabetic drugs decreases drug bioavailability; therefore, there is a demand for the use of novel methods to overcome this issue. The application of bile acids mixed micelles and bilosomes can provide an enhancement in drug efficacy. Bile acids are amphiphilic steroidal molecules that contain a saturated tetracyclic hydrocarbon cyclopentanoperhydrophenanthrene ring, and consist of three 6-membered rings and a 5-membered ring, a short aliphatic side chain, and a tough steroid nucleus. This review offers a comprehensive and informative data focusing on the great potential of bile acid, their salts, and their derivatives for the development of new antidiabetic drug delivery system.
Keyphrases
- glycemic control
- type diabetes
- end stage renal disease
- drug delivery
- blood glucose
- ejection fraction
- chronic kidney disease
- newly diagnosed
- induced apoptosis
- peritoneal dialysis
- cancer therapy
- weight loss
- drug induced
- insulin resistance
- risk assessment
- small molecule
- emergency department
- adverse drug
- machine learning
- endoplasmic reticulum stress
- cell death
- human health
- skeletal muscle
- climate change